Brief: Biotec Pharmacon Q1 EBITDA Loss Turns To Profit NOK 13.8 Mln

Arcticzymes Technologies ASA

23/04/2020 06:11

April 23 (Reuters) - Biotec Pharmacon ASA  BIOTEC.OL :
    * BIOTEC PHARMACON Q1 2020 REPORT
    * Q1 EBITDA PROFIT  NOK 13.8 MILLION VERSUS LOSS NOK  3.9
MILLION
YEAR AGO
    * WE EXPECT THESE SHORT-TERM UPSIDES TO CONTINUE BUT THEN
SUBSIDE
ONCE CORONAVIRUS OUTBREAK PASSES
    * Q1 SALES NOK 34.3 MILLION VERSUS NOK 14.8 MILLION YEAR AGO
    * Q1 GROSS PROFIT FOR GROUP IMPROVED 118% TO NOK 26.2
MILLION (Q1
2019: NOK 12.0 MILLION)
    * LONGER-TERM COMPANY WILL FOCUS ON SUPPORTING ITS PARTNERS
IN
DEVELOPING NEXT GENERATION OF COVID-19 DIAGNOSTIC TESTS

Source text for Eikon:  ID:nWkr8ctKbl 
Further company coverage:  BIOTEC.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))